{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:08:11Z","timestamp":1761512891701},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,21]],"date-time":"2010-10-21T00:00:00Z","timestamp":1287619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1038\/hr.2010.202","type":"journal-article","created":{"date-parts":[[2010,10,21]],"date-time":"2010-10-21T06:02:03Z","timestamp":1287640923000},"page":"47-48","source":"Crossref","is-referenced-by-count":7,"title":["Should primary aldosteronism be diagnosed among normotensive subjects during general health check-up and\/or at general outpatient clinics?"],"prefix":"10.1038","volume":"34","author":[{"given":"Tetsuo","family":"Nishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Omura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,21]]},"reference":[{"key":"BFhr2010202_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/sj.jhh.1001319","volume":"16","author":"JM Connell","year":"2002","unstructured":"Connell JM . Is there an epidemic of primary hyperaldosteronism? J Hum Hypertens 2002; 16: 151\u2013152.","journal-title":"J Hum Hypertens"},{"key":"BFhr2010202_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","volume":"21","author":"RD Gordon","year":"1994","unstructured":"Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC . High incidence of primary hyperaldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994; 21: 315\u2013318.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFhr2010202_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","volume":"14","author":"PO Lim","year":"2000","unstructured":"Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM . High prevalence of primary hyperaldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 2000; 14: 311\u2013315.","journal-title":"J Hum Hypertens"},{"key":"BFhr2010202_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/0002-9610(64)90249-1","volume":"107","author":"RP Sherwin","year":"1964","unstructured":"Sherwin RP, Conn JW . Present status of pathology of adrenal gland in hypertension. Am J Surg 1964; 107: 136\u2013143.","journal-title":"Am J Surg"},{"key":"BFhr2010202_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/jama.1968.03140330039007","volume":"205","author":"LM Fishman","year":"1968","unstructured":"Fishman LM, Kuchel O, Liddle GW, Michelakis AM, Gordon RD, Chick WT . Incidence of primary aldosteronism uncomplicated \u2018essential\u2019 hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria. JAMA 1968; 205: 497\u2013502.","journal-title":"JAMA"},{"key":"BFhr2010202_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/archsurg.1994.01420270067016","volume":"129","author":"RH Caplan","year":"1994","unstructured":"Caplan RH, Strutt PJ, Wickus GG . Subclinical hormone secretion by incidentally discovered adrenal masses. Arch Surg 1994; 129: 291\u2013296.","journal-title":"Arch Surg"},{"key":"BFhr2010202_CR7","first-page":"187","volume":"2","author":"GS Andersen","year":"1988","unstructured":"Andersen GS, Toftdahl DB, Lund JO, Strandgaard S, Nielsen PE . The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977\u20131981. J Hum Hypertens 1988; 2: 187\u2013189.","journal-title":"J Hum Hypertens"},{"key":"BFhr2010202_CR8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/bmj.2.6035.554","volume":"2","author":"G Berglund","year":"1976","unstructured":"Berglund G, Andersson O, Wilhelmsen L . Prevalence of primary and secondary hypertension: studies in a random population sample. BMJ 1976; 2: 554\u2013556.","journal-title":"BMJ"},{"key":"BFhr2010202_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0002-9343(79)90786-1","volume":"67","author":"DH Streeten","year":"1979","unstructured":"Streeten DH, Tomycz N, Anderson GH . Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med 1979; 67: 403\u2013413.","journal-title":"Am J Med"},{"key":"BFhr2010202_CR10","first-page":"549","volume":"52","author":"RM Tucker","year":"1977","unstructured":"Tucker RM, Labarthe DR . Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 through 1975. Mayo Clin Proc 1977; 52: 549\u2013555.","journal-title":"Mayo Clin Proc"},{"key":"BFhr2010202_CR11","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/archinte.1987.00370070103015","volume":"147","author":"AM Sinclair","year":"1987","unstructured":"Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JW . Secondary hypertension in a blood pressure clinic. Arch Intern Med 1987; 147: 1289\u20131293.","journal-title":"Arch Intern Med"},{"key":"BFhr2010202_CR12","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","volume":"51","author":"GL Schwartz","year":"2005","unstructured":"Schwartz GL, Turner ST . Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 2005; 51: 386\u2013394.","journal-title":"Clin Chem"},{"key":"BFhr2010202_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","volume":"21","author":"RD Gordon","year":"1994","unstructured":"Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC . High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994; 21: 315\u2013318.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFhr2010202_CR14","first-page":"2854","volume":"85","author":"KC Loh","year":"2000","unstructured":"Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young Jr WF . Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000; 85: 2854\u20132859.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFhr2010202_CR15","first-page":"1863","volume":"855","author":"CE Fardella","year":"2000","unstructured":"Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J . Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000; 855: 1863\u20131867.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFhr2010202_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","volume":"14","author":"PO Lim","year":"2000","unstructured":"Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM . High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 2000; 14: 311\u2013315.","journal-title":"J Hum Hypertens"},{"key":"BFhr2010202_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","volume":"42","author":"L Mosso","year":"2003","unstructured":"Mosso L, Carvajal C, Gonzalez A, Barraza A, Avila F, Montero J, Huete A, Gederlini A, Fardella CE . Primary aldosteronism and hypertensive disease. Hypertension 2003; 42: 161\u2013165.","journal-title":"Hypertension"},{"key":"BFhr2010202_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1440-1681.1985.tb02641.x","volume":"12","author":"SM Hamlet","year":"1985","unstructured":"Hamlet SM, Tunny TJ, Woodland E, Gordon RD . Is aldosterone\/renin ratio useful to screen a hypertensive population for primary aldosteronism? Clin Exp Pharmacol Physiol 1985; 12: 249\u2013252.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFhr2010202_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0753-3322(00)80019-0","volume":"54","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Omura M . Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Roai Hospital. Biomed Phamacother 2000; 54: 83\u201385.","journal-title":"Biomed Phamacother"},{"key":"BFhr2010202_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1291\/hypres.27.193","volume":"27","author":"M Omura","year":"2004","unstructured":"Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T . Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004; 27: 193\u2013202.","journal-title":"Hypertens Res"},{"key":"BFhr2010202_CR21","first-page":"246S","volume":"85","author":"M Naruse","year":"2009","unstructured":"Naruse M, Tanaka T, Otani S, Ogwa J, Tanabe M, Ishizuka N . PHAS-J Study Group\u2014A study on the frequency of primary aldosteronism in hypertensive patients in Japan using the network of the National Hospital Organization (NHO). Folia Endocrinologica Japonica 2009; 85: 246S.","journal-title":"Folia Endocrinologica Japonica"},{"key":"BFhr2010202_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00004872-199715010-00006","volume":"15","author":"I Komiya","year":"1997","unstructured":"Komiya I, Yamada T, Takasu N, Asawa T, Akamine H, Yagi N, Nagasawa Y, Ohtsuka H, Miyahara Y, Sakai H, Sato A, Aizawa T . An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and renin-aldosterone system. J Hypertens 1997; 15: 65\u201372.","journal-title":"J Hypertens"},{"key":"BFhr2010202_CR23","unstructured":"Committee for the Preparation of Guidelines for the Treatment of Hypertension, Japanese Society of Hypertension. Guidelines for the Treatment of Hypertension 2009. Life Science Publishing: Tokyo, 2009."},{"key":"BFhr2010202_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/hr.2010.166","volume":"34","author":"Y Ito","year":"2011","unstructured":"Ito Y, Takeda R, Karashima S, Yamamoto Y, Yoneda T, Takeda Y . Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects. Hypertens Res 2011; 34: 98\u2013102.","journal-title":"Hypertens Res"},{"key":"BFhr2010202_CR25","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1136\/bmj.1.6018.1125-a","volume":"1","author":"MH Snow","year":"1976","unstructured":"Snow MH, Nicol P, Wilkinson R, Hall R, Johnston ID, Hacking PM, Rolland C . Normotensive primary aldosteronism. BMJ 1976; 1: 1125\u20131126.","journal-title":"BMJ"},{"key":"BFhr2010202_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.7326\/0003-4819-88-5-655","volume":"88","author":"RD Zipser","year":"1978","unstructured":"Zipser RD, Speckart PF . \u2018Normotensive\u2019 primary aldosteronism. Ann Intern Med 1978; 88: 655\u2013656.","journal-title":"Ann Intern Med"},{"key":"BFhr2010202_CR27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0002-9343(80)90474-X","volume":"69","author":"H Shiroto","year":"1980","unstructured":"Shiroto H, Ando H, Ebitani I, Hara M, Numazawa K, Kawamura S, Sasaki H . Normotensive primary aldosteronism. Am J Med 1980; 69: 603\u2013606.","journal-title":"Am J Med"},{"key":"BFhr2010202_CR28","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1210\/jcem-52-5-1009","volume":"52","author":"T Kono","year":"1981","unstructured":"Kono T, Ikeda F, Oseko F, Imura H, Tanimura H . Normotensive primary aldosteronism: report of a case. J Clin Endocrinol Metab 1981; 52: 1009\u20131013.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFhr2010202_CR29","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/01.HYP.5.2.240","volume":"5","author":"M Matsunaga","year":"1983","unstructured":"Matsunaga M, Hara A, Song TS, Hashimoto M, Tamori S, Ogawa K, Morimoto K, Pak CH, Kawai C, Yoshida O . Asymptomatic normotensive primary aldoster-onism. Case report. Hypertension 1983; 5: 240\u2013243.","journal-title":"Hypertension"},{"key":"BFhr2010202_CR30","first-page":"77","volume":"71","author":"T Ogihara","year":"1982","unstructured":"Ogihara T, Maruyama A, Hata T, Naka T, Imanaka S, Kumahara Y, Matsumiya K, Ihara H, Koide T, Sagawa S, Saruta T . A zcase of normoreninemic normotensive primary aidosteronism associated with nephrocalc-inosis. Nippon Naikagakkai Zatsushi 1982; 71: 77\u201382.","journal-title":"Nippon Naikagakkai Zatsushi"},{"key":"BFhr2010202_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1507\/endocrj1954.31.159","volume":"31","author":"T Nishimiya","year":"1984","unstructured":"Nishimiya T, Kikuchi K, Oimatsu H, Ota S, Nakamura Y, Shimamoto K, Iimura O . A case of normotensive primary aldosteronism\u2013comparison with 13 previously experienced cases with hypertension. Endocrinol Jpn 1984; 31: 159\u2013164.","journal-title":"Endocrinol Jpn"},{"key":"BFhr2010202_CR32","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/BF03347840","volume":"18","author":"R Takeda","year":"1995","unstructured":"Takeda R, Matsubara T, Miyamori I, Hatakeyama H, Morise T . Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. J Endocrinol Invest 1995; 18: 370\u2013373.","journal-title":"J Endocrinol Invest"},{"key":"BFhr2010202_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0272-6386(99)70298-2","volume":"33","author":"M Nishimura","year":"1999","unstructured":"Nishimura M, Uzu T, Fujii T, Kuroda S, Nakamura S, Inenaga T, Kimura G . Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 1999; 33: 261\u2013266.","journal-title":"Am J Kidney Dis"},{"key":"BFhr2010202_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1291\/hypres.20.85","volume":"20","author":"A Tanabe","year":"1997","unstructured":"Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, Tanaka M, Seki T, Demura R, Demura H . Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res 1997; 20: 85\u201390.","journal-title":"Hypertens Res"},{"key":"BFhr2010202_CR35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1053\/meta.2002.30498","volume":"51","author":"M Omura","year":"2002","unstructured":"Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nshikawa T . Unique cases of unilateral hyperaldosteronism due to multiple adrenocortical micronodules, which can only be detected by selected adrenal venous sampling. Metabolism 2002; 51: 350\u2013355.","journal-title":"Metabolism"},{"key":"BFhr2010202_CR36","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1291\/hypres.29.883","volume":"29","author":"M Omura","year":"2006","unstructured":"Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T . Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 2006; 29: 883\u2013889.","journal-title":"Hypertens Res"},{"key":"BFhr2010202_CR37","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1291\/hypres.30.1083","volume":"30","author":"F Satoh","year":"2007","unstructured":"Satoh F, Abe T, Tanemoto M, Nakamura M, Abe M, Uruno A, Morimoto R, Sato A, Takase K, Ishidoya S, Arai Y, Suzuki T, Sasano H, Ishibashi T, Ito S . Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling. Hypertens Res 2007; 30: 1083\u20131095.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2010202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010202","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:06:22Z","timestamp":1684429582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2010202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,21]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["BFhr2010202"],"URL":"https:\/\/doi.org\/10.1038\/hr.2010.202","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,21]]}}}